ABBV vs VTRS
By Alex · Tickerpine
AbbVie Inc. vs Viatris Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | VTRS |
|---|---|---|
| Price | $248.76 | $16.10 |
| Market cap | $439.59B | $18.49B |
| P/E ratio | 70.5 | — |
| ROE | — | -2.75% |
| Profit margin | 9.80% | -2.79% |
| Revenue growth | 10.20% | 4.90% |
| Dividend yield | 2.77% | 2.98% |
| Beta | 0.28 | 0.89 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs VTRS in plain English
- ABBV is the bigger company — about 23.8× the market cap of VTRS.
- ABBV is growing revenue faster (10% vs 5%).
- VTRS has the higher dividend yield (2.98% vs 2.77%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
VTRS return calculator
See what $1,000 in Viatris Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.